LeMaitre Vascular posted Q1 2026 sales of $66.6 million, up 11% year-over-year, driven by strong product sales and geographic expansion. Gross margin improved to 72.7%, and operating income rose 41% to $17.8 million, resulting in a 42% increase in earnings per share to $0.68. The company declared a quarterly dividend of $0.25 per share and announced a $100 million share repurchase program. For 2026, LeMaitre expects 12% sales growth and 26% adjusted EPS growth, reflecting continued operational leverage and market expansion.
JASIWAY has introduced its popular Modern Sleeper Sofa Chair on Wayfair, catering to the growing demand for multifunctional furniture in small American homes. This compact, convertible chair supports seating and sleeping needs, ideal for urban apartm...
Crypto exchange VALR has launched over 200 new perpetual futures markets through an integration with decentralized liquidity provider Hyperliquid. This expansion allows users to trade leveraged long or short positions on a wide range of assets includ...
The Vanguard Financials ETF (VFH) has received a reiterated buy rating due to its attractive valuation and strong technical momentum as the Q2 earnings season approaches. Trading just above 14 times earnings with a long-term EPS growth near 12%, it o...
The Hoya Capital High Dividend Yield ETF (RIET) provides investors with exposure to high-quality REITs and a high 10.4% dividend yield. However, the fund pays out more than it earns, causing its net asset value (NAV) to decline over time. Its perform...
LAB token soared 173.94% to $16.15, becoming the top gainer in the latest trading session with a market cap of $5.05 billion. This surge reflects growing investor interest in LAB's innovative blockchain solutions. Other notable gainers include Binanc...
